Medication Management

APhA, NASPA release pharmacy workplace and well-being report findings

The American Pharmacists Association and the National Alliance of State Pharmacy Associations released the first Welcome To Pharmacy Workplace and Well-Being Reporting trends and findings report.
Camber intros generic Focalin

Generic Focalin is a central nervous system stimulant indicated for the treatment of ADHD.
Aurobindo obtains FDA approval for generic Colcrys

Colchicine tablets have a market value of $111 million for the 12 months ending November 2021, according to IQVIA.
FDA approves new indication of GSK’s Nucala

The approval allows for at-home administration in patients aged 6 to 11 years old with severe eosinophilic asthma.
Hikma to acquire Canadian assets of Teligent

The acquisition marks Hikma’s expansion into Canada and includes a portfolio of 25 sterile injectable products, three in-licensed ophthalmic products and a pipeline of seven additional products.
U.S. Court of Appeals upholds validity of Novartis’ Gilenya patent

Novartis said it expects no generic versions of Gilenya in the U.S. market for at least the next two years.
Zydus obtains FDA nod for generic Sabril

Vigabatrin is used to treat babies aged one month to 2 years old with infantile spasms.
PQA rolls out Social Determinants of Health Resource Guide

The guide profiles services that can improve medication use quality and safety.

Avalere analysis examines Medicare Part D’s plan tier placement of generics